MS Centrum Noord Nederland receives €576.805

The fundamental research project entitled ‘Astrocytes as new therapeutic targets for MS’ was recognized for its innovative and explorative nature and a step forward to a solution for multiple sclerosis.

In the Netherlands, approximately 25,000 people live with MS, which means 1:700 have this devastating disease. Therefore, scientific research is essential and holds promise of unveiling novel therapeutic treatments.

The research conducted at MSCNN is aimed at regenerating myelin, the protective insulating layer surrounding nerves, which is damaged in people with MS. Regeneration of myelin will alleviate symptoms, potentially halting disease progression, and therefore improving the quality of life for people with MS.